PMC:7096774 / 18386-20503
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 331 | 79-82 | Gene | denotes | THL | Gene:7062 |
| 334 | 381-383 | Disease | denotes | AH | MESH:D007039 |
| 335 | 458-466 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 338 | 820-823 | Gene | denotes | THL | Gene:7062 |
| 339 | 764-774 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 343 | 907-910 | Gene | denotes | THL | Gene:7062 |
| 344 | 859-862 | Gene | denotes | THL | Gene:7062 |
| 345 | 863-871 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 347 | 977-980 | Gene | denotes | THL | Gene:7062 |
| 350 | 1075-1078 | Gene | denotes | THL | Gene:7062 |
| 351 | 1126-1134 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 359 | 1490-1493 | Gene | denotes | THL | Gene:7062 |
| 360 | 1335-1343 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 361 | 1358-1364 | Disease | denotes | HUSLAB | |
| 362 | 1420-1426 | Disease | denotes | HUSLAB | |
| 363 | 1480-1486 | Disease | denotes | HUSLAB | |
| 364 | 1285-1287 | CellLine | denotes | LM | CVCL:5998 |
| 365 | 1374-1376 | CellLine | denotes | LM | CVCL:5998 |
| 367 | 1534-1541 | Species | denotes | patient | Tax:9606 |
| 369 | 1555-1557 | Disease | denotes | MJ | MESH:D009207 |
| 371 | 1692-1698 | Disease | denotes | HUSLAB | |
| 378 | 1821-1824 | Gene | denotes | CSK | Gene:1445 |
| 379 | 1994-1997 | Gene | denotes | CSK | Gene:1445 |
| 380 | 1957-1960 | Gene | denotes | THL | Gene:7062 |
| 381 | 1845-1848 | Gene | denotes | THL | Gene:7062 |
| 382 | 1876-1884 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 383 | 1913-1921 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T116 | 608-614 | Body_part | denotes | genome | http://purl.org/sig/ont/fma/fma84116 |
| T117 | 1204-1209 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T118 | 1264-1269 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
| T119 | 1798-1803 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T37 | 1204-1209 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T38 | 1264-1269 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
| T39 | 1798-1803 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T89 | 22-24 | Disease | denotes | LS | http://purl.obolibrary.org/obo/MONDO_0009723 |
| T90 | 458-466 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T91 | 585-587 | Disease | denotes | TS | http://purl.obolibrary.org/obo/MONDO_0010979|http://purl.obolibrary.org/obo/MONDO_0016455 |
| T93 | 764-772 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T94 | 863-871 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T95 | 1126-1134 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T96 | 1154-1156 | Disease | denotes | TS | http://purl.obolibrary.org/obo/MONDO_0010979|http://purl.obolibrary.org/obo/MONDO_0016455 |
| T98 | 1285-1287 | Disease | denotes | LM | http://purl.obolibrary.org/obo/MONDO_0016569 |
| T99 | 1335-1343 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T100 | 1374-1376 | Disease | denotes | LM | http://purl.obolibrary.org/obo/MONDO_0016569 |
| T101 | 1562-1564 | Disease | denotes | LS | http://purl.obolibrary.org/obo/MONDO_0009723 |
| T102 | 1876-1884 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T103 | 1913-1921 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T116 | 28-29 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T117 | 83-86 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T118 | 408-413 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tests |
| T119 | 731-736 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T120 | 829-831 | http://purl.obolibrary.org/obo/CLO_0007874 | denotes | MS |
| T121 | 1218-1219 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T122 | 1240-1250 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organising |
| T123 | 1285-1287 | http://purl.obolibrary.org/obo/CLO_0007336 | denotes | LM |
| T124 | 1374-1376 | http://purl.obolibrary.org/obo/CLO_0007336 | denotes | LM |
| T125 | 1495-1497 | http://purl.obolibrary.org/obo/PR_000010213 | denotes | MB |
| T126 | 1555-1557 | http://purl.obolibrary.org/obo/CLO_0007731 | denotes | MJ |
| T127 | 1774-1784 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organising |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T81 | 22-24 | Chemical | denotes | LS | http://purl.obolibrary.org/obo/CHEBI_73523 |
| T82 | 381-383 | Chemical | denotes | AH | http://purl.obolibrary.org/obo/CHEBI_73771 |
| T83 | 405-407 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
| T84 | 585-587 | Chemical | denotes | TS | http://purl.obolibrary.org/obo/CHEBI_73664 |
| T85 | 656-658 | Chemical | denotes | SK | http://purl.obolibrary.org/obo/CHEBI_144702 |
| T86 | 825-827 | Chemical | denotes | MP | http://purl.obolibrary.org/obo/CHEBI_73612 |
| T87 | 829-831 | Chemical | denotes | MS | http://purl.obolibrary.org/obo/CHEBI_73613 |
| T88 | 833-835 | Chemical | denotes | TP | http://purl.obolibrary.org/obo/CHEBI_73662 |
| T89 | 893-898 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T90 | 919-921 | Chemical | denotes | MM | http://purl.obolibrary.org/obo/CHEBI_53458|http://purl.obolibrary.org/obo/CHEBI_74707 |
| T92 | 968-973 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T93 | 1022-1024 | Chemical | denotes | MN | http://purl.obolibrary.org/obo/CHEBI_141442 |
| T94 | 1147-1149 | Chemical | denotes | AK | http://purl.obolibrary.org/obo/CHEBI_132403 |
| T95 | 1154-1156 | Chemical | denotes | TS | http://purl.obolibrary.org/obo/CHEBI_73664 |
| T96 | 1211-1213 | Chemical | denotes | AK | http://purl.obolibrary.org/obo/CHEBI_132403 |
| T97 | 1285-1287 | Chemical | denotes | LM | http://purl.obolibrary.org/obo/CHEBI_73584 |
| T98 | 1292-1294 | Chemical | denotes | ML | http://purl.obolibrary.org/obo/CHEBI_74705 |
| T99 | 1374-1376 | Chemical | denotes | LM | http://purl.obolibrary.org/obo/CHEBI_73584 |
| T100 | 1562-1564 | Chemical | denotes | LS | http://purl.obolibrary.org/obo/CHEBI_73523 |
| T101 | 1814-1816 | Chemical | denotes | NI | http://purl.obolibrary.org/obo/CHEBI_141421 |
| T102 | 1943-1948 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T147 | 0-143 | Sentence | denotes | Conflict of interest: LS is a co-investigator in an unrelated study, for which THL has received research funding from GlaxoSmithKline Vaccines. |
| T148 | 144-204 | Sentence | denotes | The other authors report no potential conflicts of interest. |
| T149 | 205-228 | Sentence | denotes | Authors’ contributions: |
| T150 | 229-292 | Sentence | denotes | All authors attest they meet the ICMJE criteria for authorship. |
| T151 | 293-380 | Sentence | denotes | All authors have contributed to, seen and approved the final version of the manuscript. |
| T152 | 381-584 | Sentence | denotes | AH set up and performed MN tests, participated in laboratory confirmation of COVID-19 suspicions, coordinated and participated in the collections of the Finnish population sera, and wrote the manuscript. |
| T153 | 585-655 | Sentence | denotes | TS performed the whole genome sequencing and genetic characterisation. |
| T154 | 656-714 | Sentence | denotes | SK and JH performed the IFA and WB analysis, respectively. |
| T155 | 715-824 | Sentence | denotes | PÖ isolated the virus and was responsible of the SARS-CoV-2 related biosafety level 3 laboratory work at THL. |
| T156 | 825-911 | Sentence | denotes | MP, MS, TP and JS participated in THL COVID-19 situation monitoring group work of THL. |
| T157 | 912-981 | Sentence | denotes | SB and MM participated in serological analysis planning group of THL. |
| T158 | 982-1033 | Sentence | denotes | SB contributed in the interpretation of MN results. |
| T159 | 1034-1146 | Sentence | denotes | ER set up the real-time RT-PCR method at THL and participated in laboratory confirmation of COVID-19 suspicions. |
| T160 | 1147-1210 | Sentence | denotes | AK and TS participated in collection of the convalescent serum. |
| T161 | 1211-1279 | Sentence | denotes | AK had a significant role to organising convalescent serum sampling. |
| T162 | 1280-1365 | Sentence | denotes | HKK, LM and ML were in charge of primary diagnostic of COVID-19 suspicions in HUSLAB. |
| T163 | 1366-1494 | Sentence | denotes | HKK and LM also set up the real-time RT-PCR method at HUSLAB and participated in laboratory sample logistics from HUSLAB to THL. |
| T164 | 1495-1554 | Sentence | denotes | MB was responsible for the care of the patient in hospital. |
| T165 | 1555-1629 | Sentence | denotes | MJ and LS participated in interviewing the index case and contact tracing. |
| T166 | 1630-1813 | Sentence | denotes | OV was responsible for virological and serological studies in HUSLAB and University of Helsinki, participated in the designing of the study and organising convalescent serum sampling. |
| T167 | 1814-1993 | Sentence | denotes | NI and CSK were responsible of THL laboratory confirmation of COVID-19 suspicions, participated in COVID-19 situation monitoring group work of THL and laboratory sample logistics. |
| T168 | 1994-2117 | Sentence | denotes | CSK was also responsible for the collections of the Finnish population sera and participated in the designing of the study. |